申请人:Otsuka Pharmaceutical Company, Limited
公开号:US04855292A1
公开(公告)日:1989-08-08
Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R.sup.2 is 1-pyrrolidinyl which may have 1 to 2 substituents selected from the group consisting of (i) C.sub.1 -C.sub.6 alkyl, (ii) amino-(C.sub.1 -C.sub.6)alkyl, said amino being optionally substituted by 1 or 2 substituents selected from C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkanoyl, and C.sub.1 -C.sub.6 alkoxycarbonyl, (iii) amino which may be substituted by 1 or 2 substituents selected from C.sub.1 -C.sub.6 alkyl, phenyl(C.sub.1 -C.sub.6)alkyl, C.sub.1 -C.sub.6 alkoxycarbonyl, and C.sub.1 -C.sub.6 alkanoyl, and (iv) 2-oxo-1,3-dioxolenemethylamino which is substituted by C.sub.1 -C.sub.6 alkyl; or 1-piperidinyl which may have 1 to 3 substituents selected from oxo, hydroxy, halogen and C.sub.1 -C.sub.6 alkyl, and R.sup.3 is C.sub.1 -C.sub.6 alkyl, or a pharmaceutically acceptable salt thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.
化合物的结构式为:##STR1##其中,R.sup.2是1-吡咯烷基,可以有1至2个取自下列组的取代基:(i) C.sub.1 -C.sub.6烷基,(ii) 氨基-(C.sub.1 -C.sub.6)烷基,该氨基可以被1或2个取自C.sub.1 -C.sub.6烷基、C.sub.1 -C.sub.6酰基和C.sub.1 -C.sub.6烷氧羰基的取代基取代,(iii) 氨基,可以被1或2个取自C.sub.1 -C.sub.6烷基、苯基(C.sub.1 -C.sub.6)烷基、C.sub.1 -C.sub.6烷氧羰基和C.sub.1 -C.sub.6酰基的取代基取代,以及(iv) 2-氧代-1,3-二氧杂环戊烷甲基氨基,该氨基被C.sub.1 -C.sub.6烷基取代;或1-哌啶基,可以有1至3个取自氧代、羟基、卤素和C.sub.1 -C.sub.6烷基的取代基,R.sup.3是C.sub.1 -C.sub.6烷基,或其药学上可接受的盐。这些化合物具有优异的抗微生物活性,因此可用作抗微生物剂,并且含有上述化合物作为活性成分的制药组合物。